|
Adolopment |
Adoption-Adaptation-Development |
||
|
AGREE II |
Appraisal of Guidelines for Research and Evaluation Instrument |
||
|
CPG |
Clinical Practice Guideline |
||
|
DHS |
Demographic and Health Survey |
||
|
EPG |
Egyptian Pediatrics Clinical Practice Guidelines Committee |
||
|
EPG CPG |
EPG Clinical Practice Guideline |
||
|
ERG |
External Review Group |
||
|
GAG |
Guideline Adaptation Group |
||
|
GDG |
Guideline Development Group |
||
|
GPS |
Good Practice Statement |
||
|
GRADE |
Grading of Recommendations Assessment, Development and Evaluation |
||
|
PICO |
population, intervention, comparison, and outcomes |
||
|
Patient population, intervention, professionals, outcomes, and healthcare context |
||
|
RIGHT |
A Reporting Tool for Practice Guidelines in Health Care |
||
|
ANA |
ANA |
||
|
ANCA |
ANCA |
||
|
Antinuclear antibodies |
Antinuclear antibodies |
||
|
Anti‑neutrophil cytoplasmic antibody |
Anti‑neutrophil cytoplasmic antibody |
||
|
Anti‑ds DNA |
Anti‑ds DNA |
||
|
Anti‑double stranded‑DNA |
Anti‑double stranded‑DNA |
||
|
Anti‑PLA2R Anti‑phospholipase A2 receptor antibody |
Anti‑PLA2R Anti‑phospholipase A2 receptor antibody |
||
|
ASOT |
ASOT |
||
|
Anti‑streptolysin O titer |
Anti‑streptolysin O titer |
||
|
C1q |
C1q |
||
|
C3 |
C3 |
||
|
C4 |
C4 |
||
|
CNIs |
CNIs |
||
|
CPG |
CPG |
||
|
DMS |
DMS |
||
|
EPG |
EPG |
||
|
Complement component C1q |
Complement component C1q |
||
|
Complement 3 |
Complement 3 |
||
|
Complement 4 |
Complement 4 |
||
|
Calcineurin inhibitors |
Calcineurin inhibitors |
||
|
Clinical practice guideline |
Clinical practice guideline |
||
|
Diffuse mesangial sclerosis |
Diffuse mesangial sclerosis |
||
|
Egyptian Clinical Practice Guideline Committee |
Egyptian Clinical Practice Guideline Committee |
||
|
EPG‑GPP Egyptian Clinical Practice Guideline Committee‑Good Practice |
EPG‑GPP Egyptian Clinical Practice Guideline Committee‑Good Practice |
||
|
Point |
Point |
||
|
EPG‑WG Egyptian Clinical Practice Guideline Committee‑Work Group |
EPG‑WG Egyptian Clinical Practice Guideline Committee‑Work Group |